from PR Newswire June 2023
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced that its co-founder Vittorio Sebastiano discussed the benefits of using epigenetic reprogramming delivered via Turn Bio's eTurna™ carrier system to rejuvenate skin with an audience of regenerative aesthetics experts...
"Epigenetic reprogramming promises to be a powerful tool that may transform how patients are treated," Sebastiano said. "However, this therapy must be safe, delivered precisely, and without side effects. This is why Turn Bio developed a unique RNA-based ERA™ reprogramming solution, and eTurna, a novel lipid nanoparticle delivery system to deliver the RNAs precisely and effectively to target cells and tissues and avoid side effects common with commercially available LNPs."..
Sebastiano and his team have successfully delivered Turn Bio's ERA technology using eTurna to reprogram cells...
The company's proprietary mRNA-based ERA™ technology restores optimal
gene expression by combatting the effects of aging in the epigenome...
read more here
No comments:
Post a Comment